Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (211-220 of 663) with videos related to

Pageof 67
Sort By:
Anticancer Research|April 3, 2014
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell linesEmilia Nitsch, Sormeh Mina, Ingo Brammer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 22, 2018
Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF studyHeinz Ludwig, Pere Gascón, Carsten Bokemeyer, et al.
Thrombosis Research|July 25, 2015
Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapyChristine Jacobsen, Karin Oechsle, Jessica Hauschild, et al.
Scientific Reports|July 2, 2025
A qualitative interview study on psycho-oncologists' experiences with patient deaths in GermanySvenja Wandke, Lisa Brandes, Mareike Rutenkröger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
Lung|October 20, 2011
Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysisJan K Hennigs, Hans Jörg Baumann, Stefan Schmiedel, et al.
Annals of Hematology|August 1, 2021
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemiaJasmin Wellbrock, Lena Behrmann, Jana Muschhammer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Molecular determinants of treatment response in human germ cell tumorsFrank Mayer, Hans Stoop, George L Scheffer, et al.
Journal of Cancer Survivorship : Research and Practice|September 18, 2024
Alcohol consumption in cancer patients receiving psycho-oncologic care analysis of socio-demographic, health-related and cancer-related factorsFrederike Bokemeyer, Kathleen Gali, Paulina Kiefer, et al.
JCO Precision Oncology|January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World DataCarsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Pageof 67

Showing results (211-220 of 663) with videos related to

Sort By:
Pageof 67
Anticancer Research|April 3, 2014
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell linesEmilia Nitsch, Sormeh Mina, Ingo Brammer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 22, 2018
Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF studyHeinz Ludwig, Pere Gascón, Carsten Bokemeyer, et al.
Thrombosis Research|July 25, 2015
Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapyChristine Jacobsen, Karin Oechsle, Jessica Hauschild, et al.
Scientific Reports|July 2, 2025
A qualitative interview study on psycho-oncologists' experiences with patient deaths in GermanySvenja Wandke, Lisa Brandes, Mareike Rutenkröger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trialAnja Lorch, Antje Kleinhans, Andrew Kramar, et al.
Lung|October 20, 2011
Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysisJan K Hennigs, Hans Jörg Baumann, Stefan Schmiedel, et al.
Annals of Hematology|August 1, 2021
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemiaJasmin Wellbrock, Lena Behrmann, Jana Muschhammer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Molecular determinants of treatment response in human germ cell tumorsFrank Mayer, Hans Stoop, George L Scheffer, et al.
Journal of Cancer Survivorship : Research and Practice|September 18, 2024
Alcohol consumption in cancer patients receiving psycho-oncologic care analysis of socio-demographic, health-related and cancer-related factorsFrederike Bokemeyer, Kathleen Gali, Paulina Kiefer, et al.
JCO Precision Oncology|January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World DataCarsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Pageof 67